Orphan Neuro Focus Leverage Orphazyme’s specialization in neurodegenerative orphan diseases to position solutions that address rare disease patient needs and align with payer incentives for high-need therapies.

Late-Stage Pipeline Target partnerships or out-licensing discussions around late-stage assets to accelerate broader market access, given the company’s emphasis on advancing therapies toward commercialization.

Global Reach Explore multi-region collaboration opportunities across Denmark, Switzerland, and the US to support cross-border trials, regulatory strategies, and commercial launches in high-potential markets.

Financial Reevaluation Offer commercial and therapeutic development services that align with a company navigating restructuring or creditor obligations, presenting value through cost-efficient development and strategic monetization of assets.

Strategic Partnerships Propose collaborations around asset monetization, manufacturing, or clinical development services with focus on maximizing return from asset divestitures or partnerships following recent asset sales.